Open AccessAdvanced RCC: Second-Line Axitinib Extends Progression-Free Survival vs Sorafenib
Author(s) -
Robert H. Carlson
Publication year - 2011
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000403886.70156.a1
Subject(s) - axitinib , sorafenib , medicine , oncology , progression free survival , overall survival , hepatocellular carcinoma